Challenges in the conduct of randomised controlled trials in cardiogenic shock complicating acute myocardial infarction

Cardiogenic shock (CS) following acute myocardial infarction (AMI) is a major challenge in cardiovascular care. Mortality remains high with 40%−50% after thirty days. Randomised controlled trials (RCTs) play a key role to generate evidence on optimal care in this field. However, the number of comple...

Descripción completa

Detalles Bibliográficos
Autores principales: Freund, Anne, Desch, Steffen, Thiele, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915423/
https://www.ncbi.nlm.nih.gov/pubmed/35317398
http://dx.doi.org/10.11909/j.issn.1671-5411.2022.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915423/
https://www.ncbi.nlm.nih.gov/pubmed/35317398
http://dx.doi.org/10.11909/j.issn.1671-5411.2022.02.002

Ejemplares similares